Aprea TherapeuticsAPRE
13F holders, Q1 2025 (March 31)26holders
1new positions
1sold out
1famous investor
$1.94avg. 13F price*
At the end of Q1 2025, 26 institutions reported holding Aprea Therapeutics Inc. (APRE) in their 13F filings, unchanged from Q4 2024. 1 opened new positions and 1 sold out. The largest holders were AIGH Capital Management LLC ($1.1M), Sio Capital Management, LLC ($564K) and Sphera Funds Management LTD. ($551K). One famous investor held it Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- Aprea Therapeutics Inc.
- CUSIP
- 03836J201
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q4 2024 → Q1 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $61K |
| Exits | 1 | $79 |
All 13F filers, Q4 2024 → Q1 2025: 33,106 shares bought and 160,783 shares sold, net −127,677 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 26 holders
| AIGH Capital Management LLC | 0.57% | No change | 539,300 | $1.1M |
| Sio Capital Management, LLC | 0.17% | No change | 276,603 | $564K |
| Sphera Funds Management LTD. | 0.14% | No change | 270,000 | $551K |
| Nantahala Capital Management, LLC | 0.03% | No change | 205,760 | $420K |
| Vanguard Group Inc. | 0.00% | No change | 173,842 | $355K |
| DAFNA Capital Management LLC | 0.08% | No change | 137,174 | $280K |
| Geode Capital Management, LLC | 0.00% | Add +1.1% | 43,137 | $88K |
| Morgan Stanley | 0.00% | Reduce -10.9% | 32,808 | $67K |
| Landscape Capital Management, L.L.C. | 0.01% | Reduce -12.6% | 30,878 | $63K |
| Citadel Advisors | 0.00% | New | 30,083 | $61K |
| Exome Asset Management LLC | 0.05% | Reduce -77.4% | 28,972 | $59K |
| Dimensional Fund Advisors LP | 0.00% | Reduce -2.4% | 16,655 | $34K |
| LPL Financial LLC | 0.00% | No change | 16,052 | $33K |
| HighTower Advisors, LLC | 0.00% | No change | 13,864 | $28K |
| BNP Paribas Financial Markets | 0.00% | Add +5.4% | 13,711 | $28K |
| BlackRock, Inc. | 0.00% | No change | 8,504 | $17K |
| Stonepine Capital Management, LLC | 0.01% | Reduce -31.5% | 102,242 | $14K |
| Bank of America Corp. | 0.00% | Add +0.0% | 4,852 | $10K |
| Tower Research Capital LLC (TRC) | 0.00% | Add +125.0% | 3,326 | $7K |
| Group One Trading LLC | 0.00% | No change | 824 | $2K |
| Mb, Levis & Associates, LLC | 0.00% | No change | 806 | $2K |
| WealthCollab, LLC | 0.00% | No change | 158 | $323 |
| Osaic Holdings, Inc. | 0.00% | No change | 100 | $204 |
| SBI Securities Co., Ltd. | 0.00% | No change | 40 | $82 |
| JPMorgan Chase & Co. | 0.00% | Reduce -9.1% | 10 | $20 |
| UBS Group AG | 0.00% | Reduce -100.0% | 3 | $6 |
"% of holder's portfolio" is APRE's weight in each manager's 13F, not the share of Aprea Therapeutics Inc. the manager owns.